Heligenics

Las Vegas, NV · Founded 2015 · Privately Held (backing)

Developer of a medicinal drug designed to prevent disease and heal patients afflicted with illness through genomics. Heligenics is based in Las Vegas, NV and was founded in 2015. Its last reported valuation was $17.2 million in Aug 2022. It has raised $6 million across 3 recorded rounds; the latest was a $2.6 million seed round in Aug 2024.

Last reported valuation
$17.2M
Oct 2026
Priced at
—
Total raised
$6.0M
Last round
Seed Round
Aug 2024

Who backs Heligenics?

5 investors
InvestorType
Battle Born VentureVenture capital
City of Las Vegas—
Las Vegas Foundation—
Nevada Governor's Office of Economic Development—
University of Nevada—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Heligenics investors

5 investors are on record for Heligenics, including Battle Born Venture, City of Las Vegas, Las Vegas Foundation and Nevada Governor's Office of Economic Development. The seed round in Aug 2024 drew 8 investors.

Free account
More of Heligenics with a free account
  • ·Watch Heligenics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Heligenics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View